Anti-DLL3 antibody drug conjugates and methods of use
US9011854B2 · kind B2 · utility
0Cited by
46References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2014 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Aug 22, 2034 |
Classification
- Technology area (CPC —)General
Abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.